Tokyo, April 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000057529) titled 'Transition of cancer survivors diagnosed with hereditary tumors' on April 1.
Study Type:
Observational
Primary Sponsor:
Institute - MIYAWAKI Satoko
Condition:
Condition - Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Identify transitions of cancer survivors diagnosed with hereditary tumors
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) The patient has been diagnosed with cancer and more than 4 months have passed since the completion of ant...